We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

InNexus Announces new EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces $1.25 Million Private Placement

Company targets another large product and continues expansion of antibody therapeutics pipeline.
News

Canopus BioPharma Announces Positive Results in Human Study of Peptide Cancer Vaccine

Study analyzed at Southern Research Institute shows human antibodies generated by Canopus’s peptides have anti-cancer properties.
News

NIH Scientists Identify Link between Brain Systems Implicated in Schizophrenia

The finding suggests that schizophrenia could result from a malfunction anywhere in the link between the three distinct brain circuits.
News

IPSOGEN Expands its U.S. Presence through Licensing Agreement with Quest Diagnostics

Ipsogen entered a non-exclusive license agreement with Quest for the use of the JAK2 V617F mutation in Quest Diagnostic's laboratory developed tests.
News

Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement

The collaboration will apply Deciphera's phylomechanics platform with Lilly's expertise to study B-Raf kinase inhibitors for cancer treatments.
News

Neovacs and BMD Announce OSEO Innovation Grant for Theranostics Project in Rheumatoid Arthritis

The companies have received a €7.9 million grant to support Tracker, a theranostics project concerning rheumatoid arthritis.
News

Luminex and BD Sign Agreement to Create Diagnostic Tests for Cancer

Collaboration will target development and marketing of new tools to enhance early cancer detection and intervention.
News

Study Reveals Link between Apobec3 Gene and Neutralizing Antibody Response to Retrovirus

New evidence strengthens the link between a host-cell gene Apobec3 and the production of neutralizing antibodies to retroviruses.
News

AssureRx Enters Into Strategic Relationship with Diamond Healthcare Corporation

AssureRx gets access to Diamond's managerial and clinical expertise, accelerating the development of AssureRx’s personalized medicine product for behavioral healthcare.
News

Teva Pharmaceutical Industries Extends Collaboration with Proteologics by Licensing Three Programs

Proteologics will discover and conduct early development of cancer treatments, while Teva will proceed with later stages of development and commercialization of the products.
Advertisement